PCI or CABG for severe unprotected left main coronary artery disease: making sense of the NOBLE and EXCEL trials
Year: 2017
Type: article
Abstract: Only arterial grafts used 14.3% 24.8% Results: PCI vs. CABG Primary endpoint Favors CABG No difference All-cause-mortality No difference No difference Cardiac mortality No difference No difference Total MI NR No difference Spontaneous MI Favors CABG No difference Stroke No difference No difference Total revascularization Favors CABG Favors CABG Target-lesion revascularization No difference No difference LMCA revascularization No difference NR Stent thrombosis 2% † , 0.8% (BIOMATRIX TM DES only) † 0.7% ‡ *, Australia, South America, South Korea; † , based on Kaplan-Meier 5-year estimates; ‡ , based on Kaplan-Meier 3-year estimates.ACS, acute
Source: Journal of Thoracic Disease
Authors: Anthony A. Holmes, Sripal Bangalore
Institutions: NYU Langone Health, New York University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2611070750